School of Global Studies

photo of Achim Rosemann

Mr Achim Rosemann

Post:Research Associate (Anthropology)
Location:ARTS C C206
Email:A.Rosemann@sussex.ac.uk

Telephone numbers
Internal:3295
UK:01273 873295
International:+44 1273 873295
download vCarddownload vCard to your mobile

Biography

Achim joined the International Science and Bioethics Collaborations Project in 2008 as a PhD resaercher, on the basis of a project-related ESRC grant. He was awarded the doctoral degree in 2014. Since 2011 he was also affiliated to the ESRC-funded Bionetworking in Asia Project for which he continued to work as a postdoctoral researcher until to December 2014. In 2015, after a 10 month tenure at the ERC funded Bionetworking in Asia Project, Rosemann took up a new position at the Centre for Education Studies at the University of Warwick. However, he remains affiliated to the Centre for Bionetworking and the Department of Anthropology of the University of Sussex as a research asscociate. Achim's doctoral dissertation 'Multi-polar Technoscience: clinical science collaborations in a changing world system' has focused on the forging of trans-continental knowledge partnerships in translational medicine between researchers in China, the USA, Hong Kong and Taiwan; in the context of a global research infrastructure for spinal cord injury and other neurodegenerative diseases. These processes have been analyzed in relation to debates on: a) the transition of China from a production to an innovation society, b) the global distribution of evidence based medicine and randomized controlled clinical trials, and c) the globalization of science in a context of scientific (as well as geopolitical and economic) 'multipolarization'. Achim has published findings of this study in a variety of social science and life science/medical journals (see below). 

Qualifications

Achim holds a PhD from the University of Sussex, and a Bsc and Msc in Social Anthropology from the Vrije Universiteit in Amsterdam (both awarded cum laude), as well as a minor in Asian Studies (University of Amsterdam, University of Leiden) and Mandarin Chinese (University of Leiden, University of Wuhan). He also was awarded a PGCert Teaching and Learning in Higher Education from the School of Education and Social Work at the University of Sussex (awarded in October 2013), and a certificate in Advanced Business Chinese from the Confucius Institute for Business Studies at LSE/Tsinghua University (awarded in July 2013). In 2009 Achim was affiliated as junior researcher to BIONET (a Sino-EU consortium on the ethical governance of biological and biomedical research). Between May and July 2011 he was a visiting scholar at the National University of Singapore's 'Asian Biopoleis Project'.  

Publications

1. Academic Publications (Social Science and Life Science/Biomedical Journals as well as Book Sections)

Jiang, L. and A. Rosemann (conditionally accepted) Human embryo gene editing in China: the uncertain legal status of the embryo, Biosocieties. 

Rosemann, A., Barfoot, J. and C. Blackburn (2017) Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part I) – Foreword. Regenerative Medicine, 12(6), 577-580. (September Issue 2017). 

Barfoot, J., A. Rosemann and C. Blackburn (2017) Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part II) – ForewordRegenerative Medicine, 12(7), 733-736. (October Issue 2017). 

Rosemann, A., Bortz, G., and F. Vasen (accepted). Regulatory developments for non-hematopoietic stem cell therapeutics: perspectives from the EU, the USA, Japan, China, India, Argentina and Brazil. In: X.D. Chen (ed.) A Roadmap to non-Hematopoietic Stem Cell-based Therapeutics:  From the Bench to the Clinic. Elsevier Academic Press.(Publication in 2018)

Sleeboom-Faulkner, M., Chen, H.D. and A. Rosemann (accepted). Regulatory Capacity Building and the Governance of Clinical Stem Cell Research in China. Science and Public Policy

Rosemann, A. (accepted) Balancing social justice and risk management in the governance of gene drive technology: lessons from stem cell research. In: Hauskeller, C., Manzeschke, A., and A. Pichl (Eds). The Matrix of Stem Cell Research Revisited. Routledge. (Publication in 2018)  

Rosemann, A., Jiang, L. and X.Q. Zhang (accepted). The Regulatory and Legal Situation of Human Embryo, Gamete and Germ Line Gene Editing Research and Clinical Applications in the People’s Republic of China. Commissioned Background Paper. Nuffield Council of Bioethics. 

Bortz, G., Vasen, F. and A. Rosemann (2017) Entre oportunidad y riesgo. Regulación, expectativas y políticas CTI para células madre en ArgentinaCiencia, Docencia y Tecnología, 54, 38-74.

Pham, P.V., and A. Rosemann (2017) Safety, Ethics and Regulation - Preface. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer

Rosemann, A., Zhang Z.Q,, Sui, S.L., Ely, A., and Sleeboom-Faulkner, M.  (2017) The regulatory situation for stem cell research in China: basic, preclinical and clinical research. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 275-290.

Rosemann, A. (2017) Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 291-300. 

Rosemann, A. (2017) Challenges to international stem cell clinical trials in countries with divergent regulations. In: Pham, P.V. and A. Rosemann (eds.) Stem Cells in Clinical Applications: Safety, Ethics and Regulations. Heidelberg and New York: Springer, 301-319.

Rosemann, A., L. Jiang and X.Q. Zhang (2017) Human Germ Line Gene Editing: Why comparative, cross-national studies on public viewpoints are important. Anthropology, DOI: 10.4172/2332-0915.1000175 

Sleeboom-Faulkner, M. Chekar, C. Faulkner, A. Heitmeyer, C., Marouda, M. Rosemann, A, et al. (2016) National Home-Keeping and the Regulation of Translational Stem Cell Applications: An international perspectiveSocial Science & Medicine, 153, 240-249 

Rosemann, A., Bortz, G., Vasen, F., and M. Sleeboom-Faulkner (2016) Global regulatory developments for clinical stem cell research: diversification and challenges to collaborationsRegenerative Medicine, 11(7), 647-657.

Rosemann, A. and N. Chaisinthop (2016) The pluralization of the international: networks of resistance and alter-standardization in regenerative stem cell medicine. Social Studies of Science, 46(1), 112-39. 

Rosemann, A. and M. Sleeboom-Faulkner (2016) New regulation for clinical stem cell research in China – expected impact and challenges for implementation, Regenerative Medicine, Doi:10.2217/rme.15.80

Rosemann, A. (2015) ‘Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective, Neurodegenerative Disease Management, 5(2), 85-87.

Rosemann, A. (2015) ‘Multi-country Stem Cell Trials: the Need for an International Support Structure', Stem Cell Research, 14(3), 396-400.

Rosemann, A. (2014) 'Standardization as situation-specific achievement: Regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine', Social Science & Medicine, 122, 72-80.

Rosemann, A. (2014) ‘Why regenerative stem cell medicine progresses slower than expected', Journal of Cellular Biochemistry, 15(12), 2073-2076.

Rosemann, A. (2014) 'Modalities of value, exchange, solidarity: the social life of stem cells in China', in: M. Sleeboom-Faulkner (Ed.) Stem Cell Research in Asia: Looking beyond regulatory exteriors. London/New York: Routledge. 

Rosemann, A. (2013) 'Scientific Multipolarization: Its impact on international clinical research collaborations and theoretical implications', Science Technology and Society, 18(3), 339-359. 

Rosemann, A. (2013) `Medical Innovation and National Experimental Pluralism: Insights from Clinical Stem Cell Research and Applications in China', BioSocieties, 8(1), 58-74.

Rosemann, A. (2011) `Modalities of Value, Exchange, Solidarity: Exploring the Social Life of Stem Cells in China', New Genetics and Society, 30(2)2, 181-192.

Rosemann, A. (2010) 'The IVF-Stem Cell Interface in China: Ontologies, Value-perceptions and Donation-practices of Embryonic Forms of Life ', in O. Doering (ed.), Life Sciences in Translation - A Sino-European Dialogue on Ethical Governance of the Life Sciences, BIONET, Online Textbook, delivery to the EU Commission, 168-179.

Rosemann, A. (2009) `Life without Value? Listening to the voices of embryo donors for human embryonic stem cell research in China', The Newsletter, International Institute of Asian Studies, No 52, winter 2009, 15-6. (URL: http://sro.sussex.ac.uk/53217/).

2. Special Issues and Edited Book Volumes

Rosemann, A., Barfoot, J., and C. Blackburn (2017) 'Regenerative Medicine in Society: Interdisciplinary Perspectives (Part 1)', Regenerative Medicine, 12(6), 577-731 [September issue 2017] (Press Release RegMedNet)

Barfoot, J., Rosemann, A., and C. Blackburn (2017) 'Regenerative Medicine in Society: Interdisciplinary Perspectives (Part 2)', Regenerative Medicine, 12(7), 733-892 [October issue 2017] (Press Release Eurekalert)

Pham, P.V., and A. Rosemann (2017) Stem Cells in Clinical Applications (Volume 6): Safety, Ethics and Regulation. Heidelberg and New York: Springer (Series Editor: Phuc Van Pham). ISBN 978-3-319-59164-3.

Rosemann, A. (in progress) ‘Alter-standardizing Clinical Trials’, Special Issue, Science as Culture  

3. Digital Resources and Online Publications 

EuroStemCell (2017). A Digital Gateway: Regenerative Medicine in Society. EuroStemCell Website: http://www.eurostemcell.org; Co-production with Jan Barfoot, Adam Price-Evans, Ryan Lewis, Anna Couturier, and Clare Blackburn. (Press Release EurekAlert) (Press Release RegMedNet).

This Digital Gateway is a complementary resource to the Regenerative Medicine double special issue (2017 above). It comprises 27 short contributions of leading inter-disciplinary scholars written for patients, practitioners, and the wider public).

Rosemann, A., Barfoot, J., Price-Evans, A. and C. Blackburn (2017). Regenerative Medicine in Society – Introduction to the Digital Gateway

Rosemann, A. (2017) The Regulation of Clinical Stem Cell Research and Applications: three dynamics of global regulatory diversification. RegMedNet. Spotlight to Cell Therapy Regulation (June 30, 2017). (Part 1) (Part 2) (Part 3).

Rosemann, A. (2013) ‘Stem Cell Clinical Trials’, Centre for Bionetworking, Educational Resource (URL: http://sro.sussex.ac.uk/53219/)

4. Other Publications 

Rosemann, A. (2014) 'Multi-polar Technoscience: Clinical Science Collaborations in a Changing World System', PhD Dissertation.

5. Reports

Rosemann, A. (2017) 'Germ Line Gene Editing in Global Context: Challenges and Needs from a UK Perspective', report for the Nuffield Council of Bioethics's Working Party: “Genome Editing in Human Reproduction.” 

Rosemann, A. (2015) ’Clinical stem cell research collaborations between China and the USA: opportunities, challenges, possible solutions’, client: Don Reed, Palo Alto, CA, USA (Californians for Cure; Sponsor of Roman Reed Spinal Cord Injury Research Act; CA)

Rosemann, A. (2014) ‘US FDA Regulation of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/P's), submitted to the ESRC.  

Rosemann, A., Zhang XQ., Sui SS., Su YY, and A. Ely (2013) 'Country Report: Stem Cell Research in China'; part of a working paper series of the Bionetworking in Asia Project, submitted to the ESRC.     

Rosemann, A. (2011) `Contextualizing Experimental Stem Cell Applications in China'; client: Department of Regulatory Affairs, Western Institutional Review Board (Western IRB), Olympia, USA

Rosemann, A. (2011) ‘Ethical Strategies in Stem Cell Banking: UK and Taiwan in cross-national Perspective', submitted to: Taiwan Stem Cell Bank, Hsinchu, Taiwan

Rosemann, A. (2010) `ISBC Report: Stem Cell Research in Taiwan', submitted to the ESRC.

Rosemann, A. (2009) `BIONET/LSE Research Stipend: Final Report', submitted to the European Commission.

 

Conference Papers & Presentations / Invited Lectures

(2017) 'The Genetic Modification of Human Life', invited lecture in module 'Body, Property and Politics', University of Warwick, November 30, 2017.

(2017) 'Human Germ Line Gene Editing in Global Context: Regulatory challenges and needs', 42d 4S Annual Meeting Boston, USA, August 30, 2017.

(2017) 'Balancing Social Justice and Risk Management in the Governance of Clinical Stem Cell Research', Kompetenzzentrum Ethik (MKE), Ludwig-Maximilians-Universität München, Workshop: Stem Cell Research: Regulatory and Ethical Challenges at the Threshold of Application, April 26, 2017

(2017) 'Genetics and Ethnicity', invited lecture at interdisciplinary module: Genetics, Science and Society, University of Warwick, March 9, 2017 

(2016) 'Gene drive technology: challenges to global risk management and governance', Cambridge Conference on Catastrophic Risks, Clare College, Cambridge, December 14, 2016. 

(2016) 'Governing human gene drive research: challenges from a global perspective', 41st 4S Annual Meeting Barcelona, Spain, September 2, 2016.

(2016) ‘The international governance of gene drive and stem cell research in low-to-mid income countries: balancing social justice and the management of global risks’, Arguing with Justice Seminar, Coventry, University of Warwick, June 27, 2016.

(2015) 'The pluralisation of the international: resistance and alter-standardization in regenerative stem cell medicine', 114th Annual Meeting, American Anthropological Association, Denver, Colorado, November 18-21, 2015.

(2015) 'Alter-standardization in regenerative medicine research: perspectives from China, India, Japan and the USA', 40th 4S Annual Meeting Denver, Colorado, November 11-14, 2015.

(2014) ‘Randomized controlled clinical trials in stem cell medicine: the emerging of international networks of conformity and resistance’, Global Life Sciences and Bionetworking - Cell therapy production, provision and policies, Sussex University, November 11, 2014  

(2014) 'The Biological Study of Violence and Aggression: Trends and Challenges for the Social Sciences', Genetics, Genomics and Global Health - Inequalities, Identities and Insecurities, Sussex University, July 18, 2014.

(2014) 'The biological roots of violence and severe mental illness: Assessing the (potential) role of genetic testing in reproductive decision making', 6th SIGENET Workshop: The Application of Genetic Tests in Prenatal Diagnosis: Mapping Social, Ethical and Science Issues, Berlin, January 3-6, 2014.

(2013) 'The Role of Genetic Knowledge in Identity Construction and Identity Politics', 5th Sigenet Workshop: Human Genetics and Ethnicity: Social, ethical and legal issues (in collaboration with the Genetics Society of China, BGI, and University of Sussex), Kunming, China, May 2-5, 2013. 

(2013) 'Regenerative Medicine Research as Global Collaborative Project: Opportunities, Challenges and Conflicts', Center of Bionetworking Lecture Series, University of Sussex, March 26, 2013. 

(2013) 'Clinical Innovation, International Standards, and their Discontents: Insights from the field of experimental stem cell medicine', School of Global Studies DPhil Lecture, Sussex University, February 6, 2013. 

(2012) 'Multi-polar Technoscience: Academia-initiated Clinical Research Partnerships in the Context of Scientific Multipolarization', Asian Biopoleis Workshop: Crossing Boudaries, July 27 2012, National University of Singapore, Singapore.

(2011) `Clinical Stem Cell Research in China: Internationalization and its Discontents', Lecture, University of Oldenburg, November 8, 2011. 

(2011) `International Clinical Trial Collaborations: Governance challenges from within', Berlin, Humboldt University, Charite Campus, SIGENET Health China Week, November 2 2011.

(2011) `Clinical Trials in China: Challenges from Internationalization and Modernization', Berlin, Humboldt University, Charite Campus, SIGENET Health China Week, November 2 2011.

(2011) `Integrating bioethics and social science methodology: The empirical study of high-profile clinical stem cell research in China', Chinese Academy of Medical Sciences, Center for Bioethics, Peking, China, March 29 2011

(2011) `Scientist-initiated Forms of Ethical Leadership and Governance across Countries and Cultures', SIGENET Health Workshop, Beijing Genomics Institute, Shenzhen, China, March 7-11 2011

(2010) `Ethical genealogies: diversity, conformity and silences in the regulation of hESC in China', Conference Paper:35th 4S Annual Meeting: 'STS in Global Context', University of Tokyo, August 25-29, 2010.

(2010) `Range-bound Collaborations: Negotiating proximity, engagement and distance in research encounters with life scientists', Conference Paper: International Science and Bioethics Collaborations in Asia: An End of Award Colloquium, Department of Anthropology, University of Cambridge, July 13-14 2010 

(2010) `Spaces of Translation: an Ethnographic Approach to the Study of Academic and Public-Private Partnerships in Stem Cell Based Clinical Trials', invited presentation: Center for Society, Technology and Medicine; National Cheng-Kung University, Tainan, Taiwan, January 21 2010 

(2010) `Translational Stem Cell Research: a tissue and patient centered perspective', paper presented at the: ISCB Workgroup Meeting, department of Anthropology, University of Durham, January 7 2010

(2009) `Anthropology in Transition: Rethinking Science Policy Studies from the Bottom Up', invited presentation:  Centre of Science, Technology and Society; Tsinghua University, Beijing, China, December 26, 2009

(2009) 'The Bioethics Function: Emerging regulatory orders, spaces and limits of participation in Mainland China', The 3rd International ESRC Genomics Network Conference 'Mapping the Genomic Era: Measurements and Meanings',October 7-9 2009, Cardiff University.

(2009) 'Disentangling the IVF embryo in China: Narratives of Value, Life and Hope', Bionet Final Conference: Biomedical Research in China and Europe: The Future of Research Collaborations, September 2-4 2009, London School of Economics / Wellcome Trust, London.

(2009) 'Risk trajectories of early embryonic life as paradox and social drama', Conference paper: International Science and Bioethics Collaborations Colloquium (ISBC), January 9-10 2009, University of Cambridge

(2008) 'Contested Tissues: Embryo donation and stem cell line distribution in the context of the IVF stem-cell interface in China', Conference paper: The Social Regulation of Stem Cell Research: Looking beyond regulatory exteriors in Asia, December 15 2008, University of Sussex, Brighton.

(2008) `Stem Cell Economies and Female Reproductive Labor', Conference Presentation: Annual Post-Graduate Conference of the Department of Social and Cultural Anthropology, June 4 2008, Vrije Universiteit, Amsterdam.